Research Article

[Retracted] Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study

Table 1

Comparison of general data between the two groups .

GroupGender (men/women)Average age (age)Tumor diameter (cm)Pathological type
Squamous cell carcinomaAdenocarcinomaSquamous cell carcinoma

Control group (40)28/1210228
Treatment group (40)29/1111236
0.0610.0070.0740.0650.0510.346
0.8050.9950.9410.7990.8220.556